These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 15724056)

  • 1. Use of conjugate pneumococcal vaccine by United Kingdom neonatal intensive care units.
    Moss SJ; Fenton AC; Gennery AR
    Arch Dis Child Fetal Neonatal Ed; 2005 Mar; 90(2):F187-8. PubMed ID: 15724056
    [No Abstract]   [Full Text] [Related]  

  • 2. [Incidence of invasive pneumococcal infection in children aged less than two years. The heptavalent pneumococcal conjugate vaccine. Situation in Spain].
    Blanco Quirós A; Giménez Sánchez F; Asensi Botet F; Bernaola Iturbe E; Martín Fde J; García Pérez J; Garcés Sánchez M; Gómez Campderá JA; Picazo JJ; Pineda Solas V;
    An Esp Pediatr; 2002 Oct; 57(4):287-9. PubMed ID: 12392660
    [No Abstract]   [Full Text] [Related]  

  • 3. Worldwide progress in introducing pneumococcal conjugate vaccine, 2000-2008.
    Wkly Epidemiol Rec; 2008 Oct; 83(43):388-92. PubMed ID: 18949860
    [No Abstract]   [Full Text] [Related]  

  • 4. [Advice of the French Superior Council on Public Health (section on transmissible diseases) relative to vaccination by heptavalent pneumococcal conjugate vaccine (Prevanar). Meeting of March 8, 2002].
    Arch Pediatr; 2002 Aug; 9(8):862-4. PubMed ID: 12212580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the recommendations for the routine use of pneumococcal conjugate vaccine for infants. An Advisory Committee Statement (ACS).
    National Advisory Committee on Immunization (NACI)
    Can Commun Dis Rep; 2006 May; 32(ACS-4):1-6. PubMed ID: 16718922
    [No Abstract]   [Full Text] [Related]  

  • 6. Under usage of conjugate pneumococcal vaccine in the Irish neonatal population.
    Breatnach C; McMahon P
    Ir Med J; 2007 Jan; 100(1):345. PubMed ID: 17380930
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of pneumococcal conjugate vaccine on the prevention of invasive pneumococcal diseases.
    Bricks LF; Berezin E
    J Pediatr (Rio J); 2006 Jul; 82(3 Suppl):S67-74. PubMed ID: 16721440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of serious bacterial infections in new-onset nephrotic syndrome: a survey of current practices.
    Shroff A; Frank R; Vergara M; Gauthier B; Trachtman H
    Clin Pediatr (Phila); 2002; 41(1):47-9. PubMed ID: 11866366
    [No Abstract]   [Full Text] [Related]  

  • 9. ACIP extends delay in pneumococcal immunization of healthy children.
    Am J Health Syst Pharm; 2002 Feb; 59(3):228. PubMed ID: 11862630
    [No Abstract]   [Full Text] [Related]  

  • 10. Measuring the impact of PCV7 in the European Union: why it is a priority.
    Lopalco PL
    Euro Surveill; 2007 Jun; 12(6):E070614.6. PubMed ID: 17868579
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the indirect effects of a pneumococcal vaccine in a community-randomized study.
    Moulton LH; O'Brien KL; Reid R; Weatherholtz R; Santosham M; Siber GR
    J Biopharm Stat; 2006; 16(4):453-62. PubMed ID: 16892907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of PCV7 on invasive pneumococcal disease among children younger than 5 years: a population-based study.
    Ramani RR; Hall WN; Boulton M; Johnson DR; Zhu BP
    Am J Public Health; 2004 Jun; 94(6):958-9. PubMed ID: 15249298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pneumococcal pneumonia in the UK--how herd immunity affects the cost-effectiveness of 7-valent pneumococcal conjugate vaccine (PCV).
    McIntosh ED; Conway P; Willingham J; Hollingsworth R; Lloyd A
    Vaccine; 2005 Feb; 23(14):1739-45. PubMed ID: 15705480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of occult bacteremia among highly febrile young children in the era of the pneumococcal conjugate vaccine: a study from a Children's Hospital Emergency Department and Urgent Care Center.
    Stoll ML; Rubin LG
    Arch Pediatr Adolesc Med; 2004 Jul; 158(7):671-5. PubMed ID: 15237067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-marketing effectiveness of Prevnar [pneumococcal 7-valent conjugate vaccine (diphtheria CRM197 protein)] and implications for adult immunization.
    Parijs BA; Malinoski FJ
    Mech Ageing Dev; 2004 Feb; 125(2):147-8. PubMed ID: 15037021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect effects associated with widespread vaccination of infants with heptavalent pneumococcal conjugate vaccine (PCV7; Prevnar).
    Isaacman DJ; Fletcher MA; Fritzell B; Ciuryla V; Schranz J
    Vaccine; 2007 Mar; 25(13):2420-7. PubMed ID: 17049677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive pneumococcal disease and the need for the new 13-valent pneumococcal vaccine.
    Bolton M; Barson W
    Pediatr Ann; 2010 Aug; 39(8):497-503. PubMed ID: 20704146
    [No Abstract]   [Full Text] [Related]  

  • 18. Pneumococcal conjugate vaccines: proceedings from an interactive symposium at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy.
    Pelton SI; Dagan R; Gaines BM; Klugman KP; Laufer D; O'Brien K; Schmitt HJ
    Vaccine; 2003 Apr; 21(15):1562-71. PubMed ID: 12639477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Swiss vaccinology update: new glycoconjugate vaccines against pneumococcal and meningococcal infections].
    Siegrist CA
    Rev Med Suisse; 2011 Jan; 7(278):154-8. PubMed ID: 21400950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?
    Moore MR; Whitney CG
    Clin Infect Dis; 2008 Jan; 46(2):183-5. PubMed ID: 18171248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.